In a statement to CBS News about this lawsuit and others against it, Novo Nordisk said in part, "The known risks and benefits of semaglutide and liraglutide medicines are described in their FDA-approved product labeling." The company wrote that "the allegations in the lawsuits are without merit" and said it intends to "vigorously defend against these claims." Novo Nordisk also said semaglutide, the drug sold under the Ozempic and Wegovy brand names, has been extensively examined in robust clinical development programs and large real world evidence studies
The other ingredients are disodium phosphate dihydrate, propylene glycol, phenol, sodium hydroxide/hydrochloric acid (for pH adjustment), and water for injection
Hasta el momento, nicamente Saxenda estaba autorizado para la indicacin de control de peso pero recientemente se han autorizado varias presentaciones de un nuevo medicamento, Wegovy que se prev que se comercialice a partir de mayo de 2024
Providers prescribing these compounds must hold appropriate DEA prescriber registration, and the dispensing pharmacy must hold a valid DEA registration authorizing Schedule IIV controlled substances
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout (GHRHKO) mouse
A medical cooling case is a worthwhile investment if you frequently transport your medication